+948.4%
MRNA vs TCOM
+42.3%
+906.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | TCOM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -4.1% | +1.9% | -1.4% |
| 7D | -12.7% | -7.0% | -5.7% | -11.6% |
| 30D | -20.7% | +3.1% | -23.7% | -21.1% |
| 3M | +46.3% | -12.7% | +59.0% | +49.6% |
| 6M | +305.2% | -16.6% | +321.8% | +316.9% |
| YTD | +561.2% | -43.7% | +604.9% | +613.7% |
| 1Y | +772.1% | -42.0% | +814.0% | +837.7% |
| 3Y | +147.0% | +11.0% | +135.9% | +141.8% |
| 5Y | -26.1% | +40.3% | -66.3% | -32.5% |
| All | +948.4% | +42.3% | +906.1% | +772.8% |
Cumulative growth
Daily Returns
Daily percentage return beside TCOM.
Daily Out/Under-Performance
Portfolio return minus TCOM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TCOM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded TCOM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling